Actuate CEO RSUs Vest; Shares Withheld for Taxes
Actuate Therapeutics, Inc. reported equity compensation activity for President, CEO and Director Daniel M. Schmitt on August 14, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Actuate Therapeutics, Inc. reported equity compensation activity for President, CEO and Director Daniel M. Schmitt on August 14, 2026. A block of 272,056 restricted stock units vested and settled into the same number of common shares, consistent with prior grants. To cover federal and state tax withholding on this settlement, 120,521 shares of common stock were withheld by the company at a per-share value of $1.01. Following these transactions, Schmitt is also shown as trustee for several irrevocable family trusts, including one holding 564,071 common shares and others each holding 22,223 shares, which are reported as indirect ownership.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F4, F5 | 272,056 | $0.00 | $0.00 |
| Exercise | Common Stock F3, F4 | 272,056 | $0.00 | $0.00 |
| Tax Withholding | Common Stock F1, F2 | 120,521 | $1.01 | $122K |
| holding | Common Stock F6 | -- | -- | -- |
| holding | Common Stock F7 | -- | -- | -- |
| holding | Common Stock F8 | -- | -- | -- |
| holding | Common Stock F9 | -- | -- | -- |
Footnotes (9)
- F1. Represents 120,521 shares of common stock withheld by Issuer to satisfy federal and state withholding taxes owed by holder upon the settlement of restricted stock units ("RSUs").
- F2. Represents the closing price of Issuer's common stock on August 14, 2026.
- F3. Represents the issuance of 272,056 shares of common stock from the vesting and settlement of 272,056 RSUs, which number excludes the withholding of 120,521 shares by Issuer to satisfy federal and state withholding taxes due at settlement (see Note 1).
- F4. Each restricted stock unit represents a contingent right to receive one share of common stock.
- F5. 544,111 restricted stock units were granted upon the closing of the issuer's initial public offering on August 14, 2024, of which, 272,055 vested on August 14, 2025 (and settled on February 13, 2026) and 272,056 vested on August 14, 2026.
- F6. Represents shares held by The Schmitt Family Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee (the "Schmitt Family Trust").
- F7. Represents shares held by The Andrew Schmitt Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee.
- F8. Represents shares held by The Anna Schmitt Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee.
- F9. Represents shares held by The Edward Schmitt Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee.
Key Figures
Key Terms
Restricted Stock Units financial
withholding taxes financial
irrevocable trust financial
initial public offering financial
Code F financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity award activity did ACTU report for CEO Daniel Schmitt on this Form 4?
What RSU grant history does the ACTU Form 4 disclose for Daniel Schmitt?
Was the ACTU CEO’s August 2026 transaction described as a market sale or tax withholding?
AI-generated analysis. How Rhea-AI works. Not financial advice.